(Q40519085)

English

A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia.

scientific article published on 15 December 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15599778%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15599778%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Alessandra Larocca

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15599778%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Fausto Rossini

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15599778%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Elisabetta Terruzzi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15599778%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Luisa Verga

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15599778%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Sara Marinoni

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15599778%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Isabella Miccolis

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15599778%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Giuseppe Giltri

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15599778%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Manuela Isella

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15599778%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Matteo Parma

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15599778%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Enrico M Pogliani

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15599778%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

15 December 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15599778%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Supportive Care in Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15599778%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15599778%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15599778%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

387-392

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15599778%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

https://scigraph.springernature.com/pub.10.1007/s00520-004-0753-8

0 references

Once-daily aminoglycoside therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00520-004-0753-8

21 January 2018

Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00520-004-0753-8

21 January 2018

Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Tre

1 reference

https://api.crossref.org/works/10.1007%2FS00520-004-0753-8

21 January 2018

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence and outcome of pneumonia in patients with acute leukemia receiving first induction therapy with anthracycline-containing regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pseudomonas aeruginosa--still a frequent pathogen in patients with cancer: 11-year experience at a comprehensive cancer center

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. The International Antimicrobial Therapy Cooperative Group of t

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ceftriaxone/Amikacin vs Ceftazidime/Amikacin as Empirical Therapy for Fever in Patients with Haematological Malignancy and Severe Granulocytopenia: Clinical and Economic Outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40519085&oldid=1584825841"